199 related articles for article (PubMed ID: 8710849)
1. Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI.
Evers M; Saftig P; Schmidt P; Hafner A; McLoghlin DB; Schmahl W; Hess B; von Figura K; Peters C
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8214-9. PubMed ID: 8710849
[TBL] [Abstract][Full Text] [Related]
2. Arylsulfatase B-deficient mucopolysaccharidosis in rats.
Yoshida M; Noguchi J; Ikadai H; Takahashi M; Nagase S
J Clin Invest; 1993 Mar; 91(3):1099-104. PubMed ID: 8450039
[TBL] [Abstract][Full Text] [Related]
3. Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.
Entchev E; Jantzen I; Masson P; Bocart S; Bournique B; Luccarini JM; Bouchot A; Lacombe O; Junien JL; Broqua P; Tallandier M
PLoS One; 2020; 15(5):e0233032. PubMed ID: 32413051
[TBL] [Abstract][Full Text] [Related]
4. Cardiac and ocular pathologies in a mouse model of mucopolysaccharidosis type VI.
Strauch OF; Stypmann J; Reinheckel T; Martinez E; Haverkamp W; Peters C
Pediatr Res; 2003 Nov; 54(5):701-8. PubMed ID: 12904606
[TBL] [Abstract][Full Text] [Related]
5. Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
Crawley AC; Yogalingam G; Muller VJ; Hopwood JJ
J Clin Invest; 1998 Jan; 101(1):109-19. PubMed ID: 9421472
[TBL] [Abstract][Full Text] [Related]
6. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes.
Isbrandt D; Arlt G; Brooks DA; Hopwood JJ; von Figura K; Peters C
Am J Hum Genet; 1994 Mar; 54(3):454-63. PubMed ID: 8116615
[TBL] [Abstract][Full Text] [Related]
7. Preliminary molecular analysis of a case of feline mucopolysaccharidosis VI.
De Luca T; Minichiello L; Leone A; Di Natale P
Biochem Biophys Res Commun; 1993 Nov; 196(3):1177-82. PubMed ID: 7504466
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI].
Zheng J; Huang Y; Zhao X; Sheng H; Cheng J; Zhou Z; Li X; Mao X; Liu L
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):403-8. PubMed ID: 25190157
[TBL] [Abstract][Full Text] [Related]
9. Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy.
Fillat C; Simonaro CM; Yeyati PL; Abkowitz JL; Haskins ME; Schuchman EH
J Clin Invest; 1996 Jul; 98(2):497-502. PubMed ID: 8755662
[TBL] [Abstract][Full Text] [Related]
10. Pathological characteristics of mucopolysaccharidosis VI in the rat.
Yoshida M; Ikadai H; Maekawa A; Takahashi M; Nagase S
J Comp Pathol; 1993 Aug; 109(2):141-53. PubMed ID: 8245230
[TBL] [Abstract][Full Text] [Related]
11. Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients.
Litjens T; Brooks DA; Peters C; Gibson GJ; Hopwood JJ
Am J Hum Genet; 1996 Jun; 58(6):1127-34. PubMed ID: 8651289
[TBL] [Abstract][Full Text] [Related]
12. Mucopolysaccharidosis VI.
Valayannopoulos V; Nicely H; Harmatz P; Turbeville S
Orphanet J Rare Dis; 2010 Apr; 5():5. PubMed ID: 20385007
[TBL] [Abstract][Full Text] [Related]
13. Restoration of arylsulphatase B activity in human mucopolysaccharidosis-type-VI fibroblasts by retroviral-vector-mediated gene transfer.
Peters C; Rommerskirch W; Modaressi S; von Figura K
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):499-504. PubMed ID: 1904721
[TBL] [Abstract][Full Text] [Related]
14. Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome.
Jezyk PF; Haskins ME; Patterson DF; Mellman WJ; Greenstein M
Science; 1977 Nov; 198(4319):834-6. PubMed ID: 144321
[TBL] [Abstract][Full Text] [Related]
15. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B.
Wicker G; Prill V; Brooks D; Gibson G; Hopwood J; von Figura K; Peters C
J Biol Chem; 1991 Nov; 266(32):21386-91. PubMed ID: 1718978
[TBL] [Abstract][Full Text] [Related]
16. Animal models for lysosomal storage diseases: a new case of feline mucopolysaccharidosis VI.
Di Natale P; Annella T; Daniele A; Spagnuolo G; Cerundolo R; de Caprariis D; Gravino AE
J Inherit Metab Dis; 1992; 15(1):17-24. PubMed ID: 1583873
[TBL] [Abstract][Full Text] [Related]
17. Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation.
Kunieda T; Simonaro CM; Yoshida M; Ikadai H; Levan G; Desnick RJ; Schuchman EH
Genomics; 1995 Oct; 29(3):582-7. PubMed ID: 8575749
[TBL] [Abstract][Full Text] [Related]
18. Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation.
Gasper PW; Thrall MA; Wenger DA; Macy DW; Ham L; Dornsife RE; McBiles K; Quackenbush SL; Kesel ML; Gillette EL
Nature; 1984 Nov 29-Dec 5; 312(5993):467-9. PubMed ID: 6438532
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Mucopolysaccharidosis Type VI through Integrative Functional Metabolomics.
Tebani A; Abily-Donval L; Schmitz-Afonso I; Piraud M; Ausseil J; Zerimech F; Pilon C; Pereira T; Marret S; Afonso C; Bekri S
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669586
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel arylsulfatase B gene mutation in three unrelated Iranian mucopolysaccharidosis type-VI patients with different phenotype severity.
Nouri N; Nouri N; Aryani O; Kamalidehghan B; Houshmand M
Iran Biomed J; 2012; 16(3):169-71. PubMed ID: 23023219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
